Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
4.070
-0.190 (-4.46%)
At close: Jan 30, 2026, 4:00 PM EST
4.090
+0.020 (0.49%)
After-hours: Jan 30, 2026, 6:49 PM EST
Exicure Employees
Exicure had 8 employees as of March 31, 2025. The number of employees increased by 1 or 14.29% since the number was last reported on December 31, 2024.
Employees
8
Change
1
Growth
14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,153,625
Market Cap
25.94M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 8 | 1 | 14.29% |
| Dec 31, 2024 | 7 | 1 | 16.67% |
| Dec 31, 2023 | 6 | -7 | -53.85% |
| Dec 31, 2022 | 13 | -34 | -72.34% |
| Dec 31, 2021 | 47 | -16 | -25.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Boundless Bio | 64 |
| Senti Biosciences | 34 |
| Palatin Technologies | 29 |
| Daré Bioscience | 23 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Rallybio | 15 |
XCUR News
- 9 days ago - Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings - GlobeNewsWire
- 7 weeks ago - Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial - Benzinga
- 7 weeks ago - Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting - GlobeNewsWire
- 3 months ago - Exicure, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting - GlobeNewsWire
- 3 months ago - Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 4 months ago - Exicure Highlights Recent Achievements and Near-term Strategic Priorities - GlobeNewsWire
- 6 months ago - Exicure, Inc. Reports Second Quarter 2025 Financial Results - Business Wire